Browsing: Access2

Health Sciences Authority (HSA) is Singapore’s national authority regulating health products, including medications. Every month, HSA publishes a list of…

Semaglutide tablet (Rybelsus), the first GLP-1RA developed for oral administration, heralds a milestone for diabetes management in the 15 years…

Hot on the heels of sotrovimab, the Health Science’s Authority  (HSA) has granted pandemic special access route (PSAR) interim authorization…

It is estimated that 15% to 20% of women with newly diagnosed breast cancer have tumours that over-express human epidermal…

In May 2021, the Health Sciences Authority (HSA) approved the use of Romosozumab (Evenity), a novel biologic, for the treatment…

Health Sciences Authority (HSA) is Singapore’s national authority regulating health products, including medications. Every month, HSA publishes a list of…

Health Sciences Authority (HSA) is Singapore’s national authority regulating health products, including medications. Every month, HSA publishes a list of…

As the COVID-19 pandemic enters into its 18-month mark, the global race for novel therapeutics blazes on, with international guidelines…

Health Sciences Authority (HSA) is Singapore’s national authority regulating health products, including medications. Every month, HSA publishes a list of…

Health Sciences Authority (HSA) is Singapore’s national authority regulating health products, including medications. Every month, HSA publishes a list of…